BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

XOMA Inc.

About XOMA Inc.

XOMA develops biopharmaceuticals that target cancer, immunological disorders and infectious diseases.

 

LEAD PRODUCT --RAPTIVA -- control of chronic moderate-to-severe plaque psoriasis --APPROVED

 

PRODUCT PIPELINE

 

Neuprex - infectious and inflammatory conditions, congenital heart abnormalities

XMP.629 -- Acne

MLN2222 - Coronary artery bypass graft (CABG) surgery patients.

 

More on XOMA

Home page

Key Statistics for XOMA

Basic Chart for XOMA

Analyst Opinion

Analysts Estimates

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com